Baskhanbio Pharma Inc. (XKON:354390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,290.00
+20.00 (0.38%)
At close: Jul 4, 2025, 3:30 PM KST

Baskhanbio Pharma Market Cap

Baskhanbio Pharma has a market cap or net worth of 37.20 billion as of July 7, 2025. Its market cap has decreased by -17.96% in one year.

Market Cap
37.20B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,290.00

Market Cap Chart

Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 37.20B, a decrease of -55.08%. That is a compound annual growth rate of -23.64%.

History

DateMarket Cap% Change
Jul 7, 202537.20B23.54%
Dec 30, 202430.11B-36.91%
Dec 28, 202347.72B16.64%
Dec 29, 202240.92B-50.59%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Electronics 414.65T
SK hynix 186.74T
Samsung Biologics 73.88T
LG Energy Solution 72.66T
Hyundai Motor Company 45.94T
KB Financial Group 40.82T
Celltrion 39.31T
Kia Corporation 38.63T
Market Cap Rankings